Skip to main content
. 2017 May 20;8(57):96697–96709. doi: 10.18632/oncotarget.18043

Figure 5. Riluzole reduces tumor formation of GBM stem-like cells in in vivo CAM assay.

Figure 5

Implantation of 64SP trypsinized GBM stem-like cells in CAM assay showed the formation of tumors that had reduced growth after the treatment with 50 µM riluzole. In another set of experiments (3×), the formation of tumors was monitored after the treatment with 10 and 50 µM riluzole in combination with the radiation. The applied dose was 5 Gy. Statistical analysis was performed using two-sided t-tests for two-group comparisons (*p < 0.05, **p < 0.01, ***p < 0.001).